InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2024-05-28 00:00:00 ET · period of report 2024-05-23 · accession 0001415889-24-014661 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-28 2024-05-23 PCVX PICKERING GRANT CEO, Dir M - OptEx $2.03 +15.0K 492.8K +3% +$30.4K
DM 2024-05-28 2024-05-23 PCVX PICKERING GRANT CEO, Dir S - Sale+OE $69.43 -15.0K 486.6K -3% -$1.04M
D 2024-05-28 2024-05-23 PCVX PICKERING GRANT CEO, Dir M - OptEx $0.00 -15.0K 212.3K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-23 M A 15,000 $2.03 492,847 D — —
2 Common Common Stock 2024-05-23 S D 8,789 $69.84 477,847 D — — (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $69.56 to $71.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2024-05-23 S D 6,211 $68.84 486,636 D — — (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $68.32 to $69.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (right to buy) 2024-05-23 M D 15,000 $0.00 212,327 D $2.03 · — to 2028-07-23 15,000 Common Stock (F6) Stock Option is fully vested and exercisable.